Brief: Dr Reddy's Receives Dcgi Approval For Zytorvi In Advanced Esophageal Squamous Cell Carcinoma
Wed 08:53
BRIEF-Dr Reddy's Receives Dcgi Approval For Zytorvi In Advanced Esophageal Squamous Cell Carcinoma Oct 21 (Reuters) - Dr. Reddy's Laboratories Limited REDY.NS:
RECEIVES DCGI APPROVAL FOR ZYTORVI IN ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Further company coverage: REDY.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Reddy's Laboratories
See all newsDr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit
Dr Reddy's beats quarterly profit estimate on India market lift (updated)
India's Dr Reddy's beats quarterly profit estimate
Brief: Dr. Reddy's Q2 Consol Net PAT 9.25 Billion Rupees
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption